Abstract
An analysis has been made of the relationship between neuron specific enolase (NSE) in serum and immunohistochemically identified occurrence of NSE in the primary tumour in 56 patients with small cell lung cancer (SCLC). Patients were referred to the Finsen Institute for treatment during a period of 18 months. Forty-six tumours (82%) were NSE positive. To compare this staining with the occurrence of NSE in serum, a histological staining index (HSI) was established by semiquantitative gradation of the staining. No significant differences were found between distribution of serum NSE values in different HSI categories, and a high ranking in HSI was not associated with a high level of serum NSE. Both univariate and multivariate analysis selected serum NSE and not HSI as the most influential prognostic factor in SCLC.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Jørgensen, L., Hirsch, F., Skov, B. et al. Occurrence of neuron specific enolase in tumour tissue and serum in small cell lung cancer. Br J Cancer 63, 151–153 (1991). https://doi.org/10.1038/bjc.1991.31
Issue Date:
DOI: https://doi.org/10.1038/bjc.1991.31
This article is cited by
-
Tumour markers: An overview
Indian Journal of Clinical Biochemistry (2007)
-
Serum neuron-specific enolase and immunohistochemical markers of neuroendocrine differentiation in lung cancer
Irish Journal of Medical Science (1995)